New study demonstrates efficacy of all-oral treatment regimens in adolescents with hepatitis C virus

Posted by on April 16, 2016 1:00 pm
Categories: health

Adolescents with Hepatitis C (HCV) could benefit from a combination of direct-acting antivirals, according to new data. The study demonstrated that adolescent patients with HCV genotype 1 aged 12 to 18 years who were treated for 12 weeks with a fixed dose combination of ledipasvir and sofosbuvir attained high sustained virologic response (SVR) rates.

Leave a Reply

Your email address will not be published. Required fields are marked *